CSI Market
Sign In | Register

Tandem Diabetes Care Inc (TNDM) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access TNDM quarterly Cash Flow →
Reviewing cash flow figures over time highlights how Tandem Diabetes Care Inc balances operational cash generation with investment and financing decisions.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
12 Months 		(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Operating Activities
Income-204.71
Depreciation & amortization17.67
Amortization of Other Assets1.86
Increase (Decrease) in Deferred Revenue0.00
Asset Impairment Charges0.00
Provision For Loan Losses Expensed9.48
Increase (Decrease) in Inventories24.82
Research and Development in Process0.00
Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property0.00
Share-based Compensation92.38
Income (Loss) from Equity Method Investments14.19
Gains (Losses) on Extinguishment of Debt0.00
Accretion Of Discount-
Provision Recovery Of Doubtful Accounts-
Provision For Recovery Of Doubtful Accounts-
Investment Income Amortization Of Discount-
Investment Income Net Amortization Of Discount And Premium-3.83
Increase Decrease In Contract With Customer Liability-4.79
Research And Development Asset Acquired Other Than Through Business Combination Written Off75.22
Income taxes4.36
Unrealized Gain (Loss) on Investments0.00
Accounts Receivable-50.82
Increase (Decrease) in Accounts Payable2.23
Increase (Decrease) in Accrued Liabilities-0.66
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-9.09
Other Working Capital-3.95
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities25.92
Discontinued operations0.00
Net Cash flow from Operating Activities-9.72
Investing Activities
Capital Expenditures-19.95
Sale of Capital Items0.00
Short-term Investments Proceeds171.41
Short-term Investments Acq.0.00
Payments for Leasing Costs, Commissions, and Tenant Improvements0.00
Payments To Acquire Intangible Assets And Equity Investments-
Payments To Acquire Intangible Assets And Strategic Investments-
Payments To Acquire Strategic Investments-
Increase (Decrease) in Restricted Cash0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments to Acquire Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire in Process Research and Development-78.59
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities72.88
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments-40.76
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Proceeds From Issuance Of Secondary Public Offering Net Of Offering Costs-
Proceeds From Public Offering Net Of Offering Costs-
Payments For Capped Call Options-
Payments For Capped Call Transactions-
Payment Tax Withholding Share Based Payment Arrangement Net-2.61
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-43.37
Effect of exchange rate on cash flow1.61
Discontinued operations0.00
Free Cash Flow-29.67
Total Cash Flow21.40
4 historic quarters locked

Sign in to unlock the full Tandem Diabetes Care Inc cash flow history.

Sign In Create Free Account

About Tandem Diabetes Care Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: February 19, 2026
  • Source: tndm-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001438133-26-000010

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License